Possible heart failure exacerbation associated with rosiglitazone: case report and literature review (Q35186548)

7 August 2017

1 reference

title

Possible heart failure exacerbation associated with rosiglitazone: case report and literature review (English)

1 reference

7 August 2017

1 reference

1 reference

2

Wendolyn S Gozansky

1 reference

7 August 2017

Robert Lee Page

1

1 reference

PubMed ID

12885108

7 August 2017

J Mark Ruscin

series ordinal

3

1 reference

PubMed ID

12885108

7 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

7 August 2017

1 reference

7 August 2017

23

1 reference

7 August 2017

7

1 reference

7 August 2017

945-954

1 reference

Epidemiology and clinical presentation of type 2 diabetes

7 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Role of diabetes in congestive heart failure: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Significant weight gain with rezulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Pulmonary edema associated with rosiglitazone and troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Thiazolidinedione-induced edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Cardiomyopathy and heart failure in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

The role of tumor necrosis factor in the pathophysiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Adaptation and maladaptation of the heart in diabetes: Part I: general concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Diabetes mellitus and congestive heart failure. Further knowledge needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Frequency of inappropriate metformin prescriptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Antihypertensive effects of CS-045 treatment in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Pioglitazone attenuates diet-induced hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.945.32721

10.1592/PHCO.23.7.945.32721

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12885108